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ABSTRACT
Objective: Nonhomogeneous distribution of 
cardioplegia antegradely in severe coronary 
artery stenosis and evolving acute myocardial 
infarction has been demonstrated 
experimentally. Administration of cardioplegia 
retrogradely causes homogeneous distribution 
and offers a good alternative for myocardial 
protection.
Methods: Thirty five consecutive patients with 
three vessel-disease undergoing elective 
coronary artery bypass grafting were 
prospectively randomized to receive either 
antegrade cold blood cardioplegia alone (Group 
A, n: 17) or antegrade/retrograde cold blood 
cardioplegia (Group B, n: 18). The patients in 
group B received cardioplegia half dose 
antegradely and then the other half dose was 
given retrogradely. In both groups, following the 
induction dose of cold blood cardioplegia, 500 ml 
cold blood maintenance cardioplegia every 20 
minutes and terminal warm blood cardioplegia 
were applied before the removal of the aortic 
cross clamp antegradely in group A and 
retrogradely in group B.
Results: Baseline patients characteristics did not 
differ in both groups. Myocardial temperature 
measured following the induction cardioplegia;
was significantly higher in group A than in group 
B (p<0.05). After 10 minutes of reperfusion, the 
rise in myocardial oxygen extraction and 
myocardial lactate extraction was higher in group 
A than in group B (p<0.02). CK-MB and 
Troponin-T levels at the postoperatively 12th 
hour were significantly higher in group A than in 
group B (p<0.05). Eight patients in group A, and 
4 patients in group B inotropic support was used 
because of the low cardiac output (p: NS). 
However, when compared the inotropic score of 
the two groups, it was significantly higher in 
group A than in group B (2.1±0.6 in group A, 
1.2+0.5 in group B p<0.04). In four patients in 
group A, 5 patients in group B atrial fibrillation, 
and in 5 patients in group A, 2 patients in group 
B ventricular extrasistole were observed (p:NS).
Conclusion: Antegrade/retrograde cardioplegia 
performs better protection and faster recovery 
than the antegrade cardioplegia alone.
Key W ords: Antegrade, Retrograde,
Protection, CABG
IN T R O D U C T IO N
Optimal myocardial protection is required for the 
homogeneous delivery of the cardioplégie
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solution to all parts of the heart. This is especially 
important in the presence of critical coronary 
artery stenosis. Nonhomogeneous distribution of 
cardioplegia antegradely in severe stenosis and 
evolving acute myocardial infarction (AMI) has 
been demonstrated experimentally (1,2).
Administration of cardioplegia through the 
coronary sinus (CS) retrogradely causes 
homogeneous distribution and offers a good 
alternative for myocardial protection (3,4). 
However, the uniformity of myocardial protection 
with retrograde cardioplegia is still controversial. 
In many studies it is emphasized that; a large 
percentage of retrograde solution was shunted 
through the arteriosinusoidal system and 
thebesian veins into the ventricular cavities, thus 
causing inadequate protection of the right 
ventricle and posterior left ventricle (5,6).
The aim of this study was to evaluate the 
metabolic effects of antegrade cardioplegia (AC), 
and antegrade / retrograde cardioplegia (ARC) in 
low-risk patients with three vessel coronary 
artery disease undergoing coronary artery 
bypass grafting (CABG).
M A T E R IA L  A N D  M E T H O D S
Patient selection: Thirty five consecutive 
patients with three vessel disease undergoing 
elective CABG were prospectively randomized to 
receive either AC alone (Group A, n: 17) or ARC 
(Group B, n:18). Patients with unstable angina 
pectoris, emergency procedures, reinterventions, 
concomitant procedures such as; valve
T a b le  I: Baseline patients' characteristics
Group A (n:17) Group B (n:18) P
Age (yr) 59.8+7.6 64.0±7.5 NS
Gender (male) 14 12 NS
Diabetes mellitus 8 5 NS
Hypertension 9 12 NS
Smoking 9 9 NS
LVEDP (mmHg) 14.4+10.1 12.3±5.0 NS
EF % 58.8±10.0 62.7±14.3 NS
VPS 8.2±1.1 8.1±1.7 NS
LVEDP: Left ventricle enddiasto/ic pressure, EF: Ejection fraction, 
VPS: Ventricular performance score, NS: Not significant
replacement were not included in the study. 
Preoperative data are summarized in Table I.
Surgical Procedure: The same surgical team 
performed all operations. Standard median 
sternotomy, full heparinization, aortic and two- 
stage venous cannula were inserted. 
Cardiopulmonary bypass (CPB) was performed 
with membrane oxygenator and non-pulsatile 
roller pump. Moderate hypothermia (rectal 
temperature 30-32 °C) was used and 2.4 
It/min/m2 flow rate was maintained during 
bypass. In group A cold blood cardioplégie 
solution was infused in the aortic root at a 
pressure of 60 mmHg and 150 mL/min flow rate, 
15 ml/kg in dose. In group B before the 
cardiopulmonary bypass (CPB) a self-inflating 
balloon cannula was placed via transatrial in 
the CS using blind insertion technique. The 
patients in group B received cardioplegia half 
dose antegradely and the other half dose was 
given retrogradely at a pressure of 40 mmHg. In 
both groups, following the induction dose of cold 
blood cardioplegia (+4 °C, 15 ml_/kg, potassium 
level: 20mEq/lt), 500 ml cold blood maintenance 
cardioplegia (+4 °C, potassium level: 10 mEq/lt) 
every 20 minutes and terminal warm blood 
cardioplegia (37°C) were applied before the 
removal of the ACC antegradely in group A and 
retrogradely in group B. Topical iceslush was 
used in all patients to support the myocardial 
protection. At the end of the first cardioplégie 
dose, myocardial temperature was measured 
with needle thermistor probes in the right 
ventricle free wall (RVFW), inferior wall (IW), 
septum and left ventricle posterolateral wall 
(LVPW). All the distal anastomoses were 
performed on ACC. In all operations, conduit for 
bypass were included saphaneous veins or LIMA 
or combination of two. The first distal 
anastomosis was performed with vein graft to the 
right coronary artery, and was completed with 
LIMA to LAD anastomosis in both groups. 
Following each vein anastomosis, 200 mL cold 
cardioplegia was perfused through the vein to 
test the anastomos quality. Proximal 
anastomoses were performed on the ascending 
aorta on a side-biting aortic clamp. After 
myocardial reperfusion, spontaneous recovery 
of the electromechanical activity of the heart and 
the need for temporary pacing were also 
recorded. Operative variables are summarized in 
Table II.
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T a b le  II: Operative variables
Group A Group B P
CCT (min) 37.3±7.5 37.3±8.0 NS
CPBT (min) 66.5±10.6 67.7±8.8 NS
Graft per case 3.6±0.7 3.3±0.8 NS
Spontan.defibrillation 12 14 NS
Myocar. temp. (°C)
RVFW 13.5±2.2 10.5±3.0 <0.02
Septum 17.0+2.4 13.8±2.5 <0.04
Inferior 18.1±1.5 15.6+2.6 <0.05
LVPW 17.5+1.6 15.8±3.4 NS
CCT: Cross clamp time, CPBT: Cardiopulmonary bypass time, 
RVFW: Right ventricle free wall,
LVPW: Left ventricle posterolateral wall
Coronary Sinus Sampling: Coronary sinus 
sampling was done in both groups to measure 
the myocardial oxygen and lactate extraction. 
Blood samples were taken simultaneously from 
the arterial or blood cardioplegia line at the 
beginning of the CPB and 10 min. after the cross­
clamp release. The samples were analyzed for 
P02, PC02, 02 saturation, 02 content, lactate 
content and Hb. The temperature difference was 
taken into consideration and corrected during 
calculation. The following formulas were used to 
calculate myocardial 02 and lactate extraction. 
Myocardial 02 extraction (MOE) = 02 content of 
arterial blood - 02 content of CS blood (CIBA- 
cornlng 288 blood gas system), myocardial 
lactate extraction (MLE) = blood cardioplegia 
lactate content - CS lactate content (Spinreact - 
Cobas Mira Plus - Roche).
Cardiac enzyme release and myocardial 
infarction: Before the operation and at 4 hours 
and 12 hours after the operation creatin kinase - 
isoenzyme MB (CK-MB) and troponin-T were 
measured in all patients. Diagnostic criteria for 
peroperative myocardial infarction were new Q 
waves of 0.04 mm or more or a reduction in R 
waves of more than 25% in at least 2 leads in 
electrocardiography (ECG) or CK-MB level more 
than 50 IU/L.
Inotropic support score: In the peroperative or 
early postoperative period patients were 
considered to have low cardiac output (LCO) 
whenever the systolic blood pressure was lower 
than 90 mmHg and mix venous 02 saturation 
lower than 60% despite adequate preload and
optimal afterload. Inotropic support score was 
done due to the dose, the number and the using 
time of the inotropic agents (Grade 1: Dopamine 
3pg/kg/min, Grade 2: Dopamine >5 pg/kg/min 
more than 24 hours, Grade 3: Using double 
inotropic agents such as; Dopamine >5 
pg/kg/min + Adrenalin >1 pg/kg/min or triple 
inotropic agents such as; Dopamine >5pg/kg/min 
+ Adrenalin >1 pg/kg/min + Dobutamine >5 
pg/kg/min more than 48 hours).
Statistical Analysis: Data are expressed as 
means and standard deviations. Continuous and 
discrete variables were compared using analysis 
of variance and %2 analyses, respectively. A 
multivariate analysis was performed for 
comparison of preoperative and intraoperative 
data between groups. A p value of less than 0.05 
was considered significant.
RESULTS
Baseline patient characteristics: Mean age 
was 59.8 ± 7.6 years in group A and 64.0 ± 7.5 
years in group B. Gender and incidence of 
hypertension, diabetes mellitus, smoking were 
similar in both groups. Furthermore, the 
parameters of the left ventricular function did not 
differ significantly in the groups. Ventricular 
performance score (VPS) is a scoring system of 
left ventricular function due to wall motions of 
seven segments at the left and right oblique 
ventriculography (normal: 1, hypokinesia: 2, 
akinesia: 3, diskinesia: 4, aneurysm: 5).
Operative variables: Number of graft per case, 
ACC time, CPB times were similar in both 
groups. Following removal of the ACC 
spontaneous recovery of electromechanical 
activity of the heart in group A was lower than in 
group B (12/17 in group A, 14/18 in group B p: 
not significant). Myocardial temperature was 
significantly higher in RVFW, IW and septal 
segments of the heart in group A than in group B 
(p<0.05) (Table II).
Coronary sinus samples: There were no 
differences in preischemic MOE and MLE values 
in both groups. Plowever, after 10 minutes of 
reperfusion the rise in MOE and MLE (Figs 1,
2) were higher in group A than in group B
(p<0.02)
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Cardiac enzyme release and myocardial 
infarction: Postoperative levels of all enzymes 
were above normal or preoperative levels but no 
significant differences between the two groups 
were found for the preoperative and at the first 
postoperative measurement values. CK-MB and 
troponin-T levels at the postoperatively 12th hour 
(Table III) were significantly higher in group A 
than in group B (p<0.05). Peroperative Ml was 
detected in 1 patient in group A, and none in 
group B (p: not significant).
Low cardiac output: For eight patients in group 
A, and 4 patients in group B inotropic support 
was used because of the LCO (p:not significant). 
However, when compared the inotropic score of 
the two groups (Table IV), was significantly 
higher in group A than in group B (p<0.04).
Cardiac arrhythmia: In four patients in group A, 
and 5 patients in group B atrial fibrillation (AF) 
was observed during the hospital stay (p: not 
significant). Also ventricular extrasistole (VES) 
needing therapy occurred 5 patients in group A 
and 2 patients in group B (p: not significant).
T a b le  III: Cardiac enzyme release
Group A Group B P
CK-MB (IU/L)
Preoperative 1.7±0.8 1.3*0.5 NS
Postoperative 2th h 21.4*6.4 19.3*6.4 NS
Postoperative 12th h 18.0*13.0 9.3*24 <0.04
Troponin-T (pg/L)
Preoperative 0.03*0.05 0.02*0.03 NS
Postoperative 2th h 0.5*0.4 0.5*0.2 NS
Postoperative 12th h 07*0.5 0.3*0.1 <0.05
T a b le  IV : Complications
Group A Group B P
LCO 8 4 NS
Inotropic score 2.1*0.6 1.2*0.5 <0.04
Ml 1 0 NS
AF 4 5 NS
VES 5 2 NS
LCO: Low cardiac output, Ml: Myocardial infarction, 
AF: Atrial fibrillation, VES: Ventricular extrasistole
MOE (mMol/L)
Pra ACC Post ACC(10 min)
P < 0.01
Pre ACC: Pre aortic cross clamp, 
Post ACC: Post aortic cross clamp
| ■  Group A 
¡□Group B
F ig . 1 : Myocardial oxygen extraction (MOE)
D IS C U S S IO N
Today, systemic hypothermia, cardioplégie arrest 
and topical hypothermia are essentials of 
conventional myocardial protection in open-heart 
surgery. Critical coronary artery stenoses may 
prevent the homogeneous distribution of the 
cardioplégie solutions. With the increasing use of 
LIMA to the occluded LAD artery; direct 
antegrade perfusion of cardioplegia beyond the 
stenoses is technically impossible (7). 
Retrograde infusions may deliver cardioplégie 
solution beyond obstructed coronary arteries and 
may improve subendocardial perfusion (8,9). 
However, in many studies inadequate protection 
of the right ventricle with retrograde cardioplegia 
was noted (5,6,10).
Spontaneous recovery of electromechanical 
activity of the heart following removal of the ACC 
has been used as an indicator of myocardial 
protection (11). In this study no difference was
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found in both groups (12/17 in group A and 14/18 
in group B, p: NS).
Likely, the level of cardiac enzyme release is 
being thought as an essential marker of the 
myocardial protection (12-14). In our study, CK- 
MB and troponin-T level at the postoperatively 
12th hour was significantly higher in group A than 
in group B (p<0.05). This result shows faster 
myocardial recovery was constituted with ARC.
Also homogeneous and adequate cooling of the 
heart could be accepted as an indicator of 
homogeneous cardioplégie delivery. In this study 
myocardial temperature had been measured 
following the induction dose of cardioplegia and 
was found significantly lower in three segments 
(RVFW, IW, Septal segments, p<0.05) of the 
heart In group B than In group A. As we noted 
before the adequate protection of the right 
ventricle with retrograde cardioplegia is 
controversial. But in our study the lower 
myocardial temperatures of right ventricle was 
observed with ARC. It is difficult to say that the 
right ventricle is always inadequately protected 
with retrograde cardioplegia, on the contrary of 
adequate protection of left ventricle. Retrograde 
cardioplegia has a mixed effect: more
homogeneous distribution of the cardioplégie 
solution to the left ventricular microcirculation, 
especially in patients with critical coronary artery 
stenoses, (2,4,9,15) and causes the 
endocavitary cooling of the right ventricle with 
cardioplégie solution diverted from the arterial 
network through the thebesian veins and arterio­
venous shunts (16). Therefore we believe that; 
combined ARC with infusion of the cardioplégie 
solution after the right coronary artery 
anastomoses via the graft will protect the right 
ventricle adequately.
Myocardial biopsy samples were not taken in this 
study, but it has been shown that in patients with 
three vessel disease and a significant stenosis in 
the LAD, the preservation of energy-rich 
phosphates during ischemic cardiac arrest Is 
better with retrograde than with antegrade 
cardioplegia (17).
Regarding the metabolic study performed on the 
coronary sinus blood samples, the level of MOE 
and MLE did not differ significantly 
preoperatively. However, 10 min. after
reperfusion the rise in MOE and MLE levels was 
significantly higher in group A than in group B 
(p<0.02). These metabolic study results show 
that better myocardial protection was obtained by 
ARC than solely by AC.
Eight patients in group A, and 4 patients in group 
B needed inotropic support because of LCO (p: 
not significant). The inotropic score of group A 
was significantly higher (p<0.04) than in group B 
(2.1 ± 0.6 vs. 1.2 ± 0.6).
In conclusion; despite the small numbers of 
included patients, in this study the overall 
myocardial protection was satisfactory in both 
groups. There was no early mortality and no 
severe cardiac morbidity (such as; prolonged 
LCO, intractable arrhythmia) during the hospital 
stay. But some indicators of myocardial 
protection (such as; spontaneous defibrillation of 
the heart, cardiac enzyme release, myocardial 
cooling) were against the efficacy of AC. 
Therefore, ARC should be preferred, especially 
in patients with three vessel coronary artery 
disease undergoing CABG.
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